t.sandvik
Submits third-party assay reports on material purchased directly. Based in Enugu.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.06%
n=8
Suppliers covered
5
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041788 | Retatrutide | ASY | ASY-{CAT}-2288 | Janoshik | 2026-Q3 | 98.45 | 5.77 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043111 | Tirzepatide | KP | KP-2605-E6585 | Janoshik | 2026-Q2 | 98.28 | 3.70 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041396 | Oxytocin | QYB | QYB-2601-V4429 | PeptideMeter | 2026-Q2 | 99.69 | 3.97 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041805 | Exenatide | ASY | ASY-{CAT}-2827 | Janoshik | 2026-Q2 | 99.07 | 4.73 | 99.8 | Buyer-sourced | 0 | PASS |
| AX-2025-020022 | Semaglutide | SWB | SWB-2511-B7324 | Janoshik | 2025-Q4 | 98.00 | 6.34 | 91.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019993 | Semaglutide | SWB | SWB-2504-Y6911 | Janoshik | 2025-Q3 | 99.04 | 2.76 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004602 | Enclomiphene citrate | TFC | TFC-2404-J9626 | Janoshik | 2024-Q3 | 99.09 | 3.64 | 101.9 | Buyer-sourced | 0 | FAIL |
| AX-2024-004246 | Tirzepatide | QYB | QYB-2402-J4684 | Janoshik | 2024-Q1 | 99.36 | 3.55 | 101.3 | Buyer-sourced | 0 | PASS |